Evidence map›Paper›PMID 26606759›Full record

ArticlePloS one2015

Immune Responses in Acute and Convalescent Patients with Mild, Moderate and Severe Disease during the 2009 Influenza Pandemic in Norway.

Kristin G-I Mohn, Rebecca Jane Cox, Gro Tunheim, Jan Erik Berdal, Anna Germundsson Hauge, Åsne Jul-Larsen, Norwegian Pandemic Group, Bjoern Peters, Fredrik Oftung, Christine Monceyron Jonassen and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Kristin G-I MohnThe Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Rebecca Jane CoxThe Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Gro TunheimDivision of Infectious Disease Control, Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway.
Jan Erik BerdalDepartment of Infectious Diseases, Akershus University Hospital, Nordbyhagen, Norway.
Anna Germundsson HaugeSection for Virology, Department of Laboratory Services, Norwegian Veterinary Institute, Oslo, Norway.
Åsne Jul-LarsenThe Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
Norwegian Pandemic Group
Bjoern PetersDivision of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America.
Fredrik OftungDivision of Infectious Disease Control, Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway.
Christine Monceyron JonassenGenetic Unit, Department of Multidisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital, Nordbyhagen, Norway.
Siri MjaalandDivision of Infectious Disease Control, Department of Bacteriology and Immunology, Norwegian Institute of Public Health, Oslo, Norway.
Norwegian Institute of Public Health · NOLa Jolla Institute for Immunology · USAkershus University Hospital · NOUniversity of Bergen · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increased understanding of immune responses influencing clinical severity during pandemic influenza infection is important for improved treatment and vaccine development. In this study we recruited 46 adult patients during the 2009 influenza pandemic and characterized humoral and cellular immune responses. Those included were either acute hospitalized or convalescent patients with different disease severities (mild, moderate or severe). In general, protective antibody responses increased with enhanced disease severity. In the acute patients, we found higher levels of TNF-α single-producing CD4+T-cells in the severely ill as compared to patients with moderate disease. Stimulation of peripheral blood mononuclear cells (PBMC) from a subset of acute patients with peptide T-cell epitopes showed significantly lower frequencies of influenza specific CD8+ compared with CD4+ IFN-γ T-cells in acute patients. Both T-cell subsets were predominantly directed against the envelope antigens (HA and NA). However, in the convalescent patients we found high levels of both CD4+ and CD8+ T-cells directed against conserved core antigens (NP, PA, PB, and M). The results indicate that the antigen targets recognized by the T-cell subsets may vary according to the phase of infection. The apparent low levels of cross-reactive CD8+ T-cells recognizing internal antigens in acute hospitalized patients suggest an important role for this T-cell subset in protective immunity against influenza.

Indexed as

ImmunityAdultAgedAged, 80 and overAntibodies, NeutralizingAntibodies, ViralCytokinesEpitopes, T-LymphocyteFemaleHost-Pathogen InteractionsHumansImmunity, CellularImmunity, HumoralImmunoglobulin GInfluenza A virusInfluenza A Virus, H1N1 SubtypeAntibodies, NeutralizingAntibodies, ViralCytokinesEpitopes, T-LymphocyteImmunoglobulin G

Identifiers

PMID26606759
PMCPMC4659565
OpenAlexW2172862902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.